Kaftrio* (elexacaftor/tezacaftor/ivacaftor)

14,950.0017,057.00

Kaftrio (elexacaftor/tezacaftor/ivacaftor)* is a medication used in combination with ivacaftor 150 mg tablets for the treatment of cystic fibrosis (CF), indicated for CF patients aged 12 years and older who have at least one F508del mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene.

Ivacaftor 150 mg tablets are not included in the package, they are available to order here

The medicine is approved by the Food and Drugs Administration (FDA) under the brand-name Trikafta. We have it available to order as well. See [Trikafta (elexacaftor/tezacaftor/ivacaftor; ivacaftor)].

Please note that we have a generic form of edaravone available to order as well. See [Trixacar (elexacaftor/tezacaftor/ivacaftor; ivacaftor)].

 

*Kaftrio is a registered trademark by Vertex Pharmaceuticals Incorporated.

DISEASE INDICATIONS

Cystic Fibrosis

MANUFACTURER

Vertex Pharmaceuticals Incorporated

USAGE

Oral

MEDICINE APPROVED BY

  • European Medical Agency (EMA)

PATIENTS HELPED

  • Over 1.2 million patients reached

  • More than 11,000 patients helped

  • 100% successful deliveries to 88 countries

WE CAN HELP WITH YOUR IMPORT DOCUMENTS

We are experts in import regulations.

This content has been reviewed by a Medical Doctor.
KAFTRIO (ELEXACAFTOR/TEZACAFTOR/IVACAFTOR) Package

56 tablets – 75 mg of ivacaftor, 50 mg of tezacaftor and 100 mg of elexacaftor, 56 tablets – 37.5 mg of ivacaftor, 50 mg of tezacaftor and 100 mg of elexacaftor

Reviews

There are no reviews yet.

Be the first to review “Kaftrio* (elexacaftor/tezacaftor/ivacaftor)”

Your email address will not be published. Required fields are marked *

Shopping Cart